Navigation Links
Mission Pharmacal Conducts Online Survey of Osteoporosis Patients
Date:1/15/2014

SAN ANTONIO, Jan. 15, 2014 /PRNewswire/ -- Most osteoporosis patients want a choice in the medication they take, according to a recent online survey* sponsored by Mission Pharmacal Company. The survey, conducted by Inspire among the National Osteoporosis Foundation online support community, revealed that 74 percent of osteoporosis patients surveyed prefer to take medication that comes in a form other than a pill or a tablet.

(Photo: http://photos.prnewswire.com/prnh/20140115/PH47087)

Mission Pharmacal sponsored the online survey to raise awareness of osteoporosis and to encourage people to talk to their doctors about treatment options. "The results of this survey show that patients are interested in options," says Robert Recker, MD, MACP, FACE, Director, Osteoporosis Research Center, Creighton University, Omaha, Neb. "We take medication compliance very seriously because we know it can result in fewer fractures with osteoporosis."

BINOSTO® (alendronate sodium) Effervescent Tablet for oral solution (70 mg) from Mission Pharmacal delivers an easy-to-take, strawberry-flavored alternative to pills for individuals with osteoporosis who either can't or prefer not to swallow pills. It is the first and only effervescent tablet that can be dissolved in water to create a buffered solution for the treatment of osteoporosis.

Studies show that bisphosphonate treatments, such as BINOSTO, can reduce the risk of fractures with osteoporosis up to 50 percent. "At the end of the day, drugs don't work if patients don't take them," adds Jim Self, General Manager of Bone Health at Mission Pharmacal. "When we launched BINOSTO, we knew that many osteoporosis patients had difficulty swallowing pills or tablets. What we learned from this survey is that even patients who can tolerate pills still want an alternative, such as a buffered solution like BINOSTO."

According to the National Osteoporosis Foundation, 9 million people in the United States have osteoporosis and another 43 percent have low bone density. Without treatment, their bones weaken and become fragile, making them more likely to break. Ultimately, one in two women and one in four men with osteoporosis will break a bone after the age of 50.

Alendronate sodium provides fracture-risk reduction at the hip and spine and increases bone density. Until recently, it was available only in pill form. BINOSTO is formulated with the same 70 mg of alendronate sodium as other standard alendronate weekly therapies, yet it is delivered in a tablet that dissolves in water.

"Broken bones, especially in older adults, can lead to disability and even death," says Recker. "Between 20 and 25 percent of people with hip fractures will die within a year of the fracture. Of those who survive, nearly half will require help with activities of daily living.

"Many people make lifestyle changes to reduce their risk of cancer and heart disease, yet they
don't realize that osteoporosis is a common and potentially fatal disease," says Recker. "If having treatment options improves compliance, we can help more people treat osteoporosis."

Find the complete survey results at binosto.com

* Mission surveyed members of the Inspire/National Osteoporosis Foundation Support Community, a peer-to-peer support group, in June and July 2013. A total of 331 women participated in the survey; 291 of them had been diagnosed with osteoporosis.

About BINOSTO

About Mission Pharmacal Company


'/>"/>
SOURCE Mission Pharmacal Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Research Finds Optimal Adherence to Medications Prescribed Post-Heart Attack Reduces Hospital Readmissions
2. BioLineRx Announces Regulatory Submission for Novel Stem Cell Mobilization Treatment
3. When Prescribing New Drugs for Crohns Disease or Ulcerative Colitis, Surveyed EU5 Gastroenterologists Will Prioritize Remission Rates Over Cost and Reimbursement Hurdles
4. CareCentrixs HomeSTAR Program Reduces Hospital Readmissions Nearly 20 Percent Among Aetna Members
5. Elton John AIDS Foundation and Mylan Give $1 Million to Nigeria for the Elimination of Mother-to-Child Transmission of HIV
6. SynteractHCR Supports the San Diego Rescue Mission for Second Year in a Row
7. Mammoth Medical Missions Is Among the First to Provide Medical Assistance After Typhoon Haiyan Devastates the Philippines
8. Star Scientific Announces Leadership Transition, Acceleration of Plans for Submission of an IND to FDA for Pharmaceutical Version of Anatabine Compound
9. IGI Laboratories, Inc. Announces Thirteenth ANDA Submission
10. goBalto, Inc. expands Tracker 2.0s analytics and submissions features
11. The Joint Commission Issues Sentinel Event Alert on Preventing Retained Foreign Objects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
Breaking Medicine Technology:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):